Biogen price target raised to $245 from $225 by Piper Sandler
Piper Sandler raised its price target on Biogen to $245.00 per share from $225.00, according to Benzinga ratings actions.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.